AdComconf 0.85

omecamtiv mecarbil — AdCom

$CYTK · CYTOKINETICS INC · heart failure with reduced ejection fraction (HFrEF)

Event date

Date TBD

Sponsor runway

3 mo

$129.8M liquid

Evidence

“the Agency plans to convene an Advisory Committee meeting for the New Drug Application (NDA) for omecamtiv mecarbil. Cytokinetics expects the FDA to inform it of the date and topics for the Advisory Committee Meeting in a subsequent communication.”

Source: 8-K filed 2022-05-17View on EDGAR ↗0001171843-22-003762

Comparable historical adcoms· last 5 years · same event type

No comparable historical outcomes in our database yet — backfill of past readouts arrives next ingestion cycle.

Recent insider activity· ±90 days

6 insiders · 0 buys · 10 sells

Exercise10b5-1

2026-05-19

Malik Fady Ibraham

EVP Research & Development

3,500 @ $7.80$27K

Sell10b5-1

2026-05-19

Malik Fady Ibraham

EVP Research & Development

3,500 @ $75.69$265K

Sell10b5-1

2026-05-14

Blum Robert I

President & CEO

7,500 @ $77.92$584K

Sell10b5-1

2026-05-05

Lee Sung

EVP, Chief Financial Officer

23,906 @ $76.87$1.84M

Exercise10b5-1

2026-05-05

HENDERSON JOHN T

Director

20,000 @ $7.61$152K

Sell10b5-1

2026-05-05

HENDERSON JOHN T

Director

20,000 @ $75.97$1.52M

Exercise10b5-1

2026-05-05

WIERENGA WENDELL

Director

4,032 @ $12.40$50K

Sell10b5-1

2026-05-05

WIERENGA WENDELL

Director

4,032 @ $75.00$302K

Exercise10b5-1

2026-05-05

Malik Fady Ibraham

EVP Research & Development

3,500 @ $7.80$27K

Exercise10b5-1

2026-05-05

Callos Andrew

EVP, Chief Commercial Officer

11,333 @ $39.13$443K

Sell10b5-1

2026-05-05

Callos Andrew

EVP, Chief Commercial Officer

11,333 @ $77.25$875K

Sell10b5-1

2026-05-05

Malik Fady Ibraham

EVP Research & Development

3,500 @ $77.37$271K

Exercise10b5-1

2026-05-01

Callos Andrew

EVP, Chief Commercial Officer

15,857 @ $37.63$597K

Sell10b5-1

2026-05-01

Callos Andrew

EVP, Chief Commercial Officer

15,857 @ $65.00$1.03M

Exercise10b5-1

2026-04-30

Callos Andrew

EVP, Chief Commercial Officer

15,000 @ $23.26$349K

Sell10b5-1

2026-04-30

Callos Andrew

EVP, Chief Commercial Officer

15,000 @ $63.26$949K

Sell10b5-1

2026-04-29

Blum Robert I

President & CEO

7,500 @ $59.62$447K

Date	Insider	Action	Shares	Price	Value
2026-05-19	Malik Fady IbrahamEVP Research & Development	Exercise10b5-1	3,500	$7.80	$27K
2026-05-19	Malik Fady IbrahamEVP Research & Development	Sell10b5-1	3,500	$75.69	$265K
2026-05-14	Blum Robert IPresident & CEO	Sell10b5-1	7,500	$77.92	$584K
2026-05-05	Lee SungEVP, Chief Financial Officer	Sell10b5-1	23,906	$76.87	$1.84M
2026-05-05	HENDERSON JOHN TDirector	Exercise10b5-1	20,000	$7.61	$152K
2026-05-05	HENDERSON JOHN TDirector	Sell10b5-1	20,000	$75.97	$1.52M
2026-05-05	WIERENGA WENDELLDirector	Exercise10b5-1	4,032	$12.40	$50K
2026-05-05	WIERENGA WENDELLDirector	Sell10b5-1	4,032	$75.00	$302K
2026-05-05	Malik Fady IbrahamEVP Research & Development	Exercise10b5-1	3,500	$7.80	$27K
2026-05-05	Callos AndrewEVP, Chief Commercial Officer	Exercise10b5-1	11,333	$39.13	$443K
2026-05-05	Callos AndrewEVP, Chief Commercial Officer	Sell10b5-1	11,333	$77.25	$875K
2026-05-05	Malik Fady IbrahamEVP Research & Development	Sell10b5-1	3,500	$77.37	$271K
2026-05-01	Callos AndrewEVP, Chief Commercial Officer	Exercise10b5-1	15,857	$37.63	$597K
2026-05-01	Callos AndrewEVP, Chief Commercial Officer	Sell10b5-1	15,857	$65.00	$1.03M
2026-04-30	Callos AndrewEVP, Chief Commercial Officer	Exercise10b5-1	15,000	$23.26	$349K
2026-04-30	Callos AndrewEVP, Chief Commercial Officer	Sell10b5-1	15,000	$63.26	$949K
2026-04-29	Blum Robert IPresident & CEO	Sell10b5-1	7,500	$59.62	$447K

← All catalysts for $CYTK